Breaking News on Supplements, Health & Nutrition - North America EU edition | APAC edition

News > Regulation

Read more breaking news



Jarrow Formulas challenges FDA on NDIs with 128-item Freedom of Information request

1 commentBy Stephen Daniells , 16-Sep-2011
Last updated on 19-Sep-2011 at 09:58 GMT2011-09-19T09:58:22Z

Jarrow Formulas challenges FDA on NDIs with 128-item Freedom of Information request

California-based Jarrow Formulas has submitted a 128-item Freedom of Information Request to the US FDA with questions it deems ‘vital’ to any comments it seeks to file in response to the New Dietary Ingredient (NDI) draft guidance.

The Freedom of Information Request (FOIA) seeks clarification on the potential impact of the draft guidance on a number of topics, including economic, business, and public health, the costs of testing and costs of actual notifications, safety issues, and probiotics.

In addition, the FOIA asks the Food and Drug Administration (FDA) for all documents pertaining to the comment period and FDA’s process toward a final guidance, and legal definitions.

Commenting independently on the FOIA from Jarrow Formulas (JFI), Virginia-based attorney Jonathan Emord told NutraIngredients-USA: “The questions raised in the FOIA are important ones that should be answered”.

Comment extension

JFI recently submitted a request to extend the comment period from 90 days to one year, following a similar request by law firm Hyman, Phelps & McNamara, P.C. on July 26, 2011.

As reported by NutraIngredients-USA , FDA granted a 60-day extension to the comment period for the NDI draft guidance last week. The announcement pushes the comment due date to December 2, 2011.

In its FOIA letter to FDA, signed by attorneys P. Scott Polisky and Susan Brienza, Jarrow Formulas (JFI) again makes the request to extend to one year.

“Please note that production of this information [requested in the FOIA] is vital to any comments JFI and other parties may seek to file in response to the Draft Guidance.

“Per our 16-point August 29, 2011 letter to the Dockets Management Branch, we requested that FDA extend the comment period from 90 days to one year, a fair and reasonable request given the complexity of the issues and requirements involved.

“As of [September 8, 2011] the FDA has extended the Comment period by 60 days, which is still inadequate given the enormous potential impact on industry and the public health. “

The letter finishes by noting that a response should be issued within 20 working days, as required by 5 U.S.C. § 552. “[However,] we certainly understand that complete responses to this request may take longer.”

1 comment (Comments are now closed)

The Lack of Education Is At The Root of This!

Because Doctors do not study natural science and the benefits of food supplements for the treatment of disease and rely on drug companies and a share of profits is at the root of this action.
The FDA stands to make billions of dollars to review new petitions for approval.
What the FDA and Congress does to distroy the food supplement business the FTC takes up the slake.
This is all unconstitutional in my book. Where is my freedom of choice?
Shame on the efforts of Dick Durbin and the FDA!

Report abuse

Posted by Sandi
17 September 2011 | 18h032011-09-17T18:03:13Z

Related products